CRVS - Corvus Pharmaceuticals, Inc.

QQQ $ 439.55 $ -0.26 (-0.06 %)

DIA $ 390.50 $ 1.74 (0.45 %)

SPY $ 517.10 $ 0.05 (0.01 %)

TLT $ 90.18 $ -0.55 (-0.61 %)

GLD $ 213.58 $ -0.63 (-0.29 %)

Previous Close

$ 1.96

Open

$ 1.84

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.84 - $ 1.98

52 Week Range

$ 1.05 - $ 4.19

Volume

632,337

Average Volume

Market Cap

96.12M

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	03-19-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	03-28-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-01-2021	09-30-2021	10-Q
12	08-02-2021	06-30-2021	10-Q
13	04-29-2021	03-31-2021	10-Q
14	03-25-2021	12-31-2020	10-K
15	10-29-2020	09-30-2020	10-Q
16	07-30-2020	06-30-2020	10-Q
17	04-30-2020	03-31-2020	10-Q
18	03-09-2020	12-31-2019	10-K
19	10-30-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-09-2019	03-31-2019	10-Q
22	03-07-2019	12-31-2018	10-K
23	11-01-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	03-01-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-03-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	03-10-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Maintains Outperform on Corvus...
05/07/2024 12:06:09

Oppenheimer analyst Jeff Jones maintains Corvus Pharma (NASDAQ:CRVS) with a Outperform and raises the price target from $7 t...

Corvus Pharma Expects FY24 Net Cash Used I...
05/06/2024 20:03:58

Corvus Pharma Q1 2024 GAAP EPS $(0.12), In...
05/06/2024 20:02:03

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate.

Corvus Pharmaceuticals Announces Pricing O...
05/02/2024 12:40:18

Corvus Pharmaceuticals, Inc. (Corvus or the Company) (NASDAQ:CRVS) (GLOBAL NEWSWIRE), a clinical-stage biopharmaceutical compan...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 20:31:18

Corvus Pharmaceuticals Announces Initiatio...
04/09/2024 20:02:18

Atopic dermatitis is the first immune disease indication being studied in the clinic for soquelitinib, the Company's select...

Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 15:16:33

Cantor Fitzgerald analyst Li Watsek reiterates Corvus Pharma (NASDAQ:CRVS) with a Overweight.

Mizuho Maintains Neutral on Corvus Pharma,...
03/27/2024 17:21:58

Mizuho analyst Graig Suvannavejh maintains Corvus Pharma (NASDAQ:CRVS) with a Neutral and maintains $3.5 price target.

Oppenheimer Maintains Outperform on Corvus...
03/20/2024 11:14:14

Oppenheimer analyst Jeff Jones maintains Corvus Pharma (NASDAQ:CRVS) with a Outperform and lowers the price target from $8 t...

Corvus Pharma Q4 EPS $(0.14) Misses $(0.12...
03/19/2024 20:04:29

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.1...

Earnings Scheduled For March 19, 2024
03/19/2024 10:06:23

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per...

Earnings Outlook For Corvus Pharma
03/18/2024 14:00:39

Corvus Pharmaceuticals Presents Soquelitin...
02/12/2024 13:31:23

The poster presentation includes the first description of Corvus' next-generation ITK inhibitor preclinical product candida...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
02/09/2024 13:06:11

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
02/08/2024 21:31:10

Corvus Pharmaceuticals Says FDA Granted Or...
02/08/2024 21:09:37

Soquelitinib, the Company's lead ITK inhibitor candidate, is expected to advance into a Phase 3 registrational clinical tri...

why-green-giant-shares-are-trading-lower-by-around-37-here-are-20-stocks-moving-premarket

Why Green Giant Shares Are Trading Lower B...
12/11/2023 12:59:28

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Gre...

Saturday, Corvus Pharmaceuticals Announced...
12/11/2023 10:07:22

Corvus Pharma Q3 EPS $(0.12), Inline
11/07/2023 22:06:17

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a ...

Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.